Towards Healthcare
Antipyretic and Analgesic Drugs Market to Lead USD 77.99 Bn by 2034

Antipyretic and Analgesic Drugs Market Drive Safer Pain Management

According to market projections, the global antipyretic and analgesic drugs market, valued at USD 47.47 billion in 2024, is anticipated to reach USD 77.99 billion by 2034, growing at a CAGR of 5.09% over the next decade. The rising prevalence of fever, headache, muscle pain, and inflammation-related conditions has driven the growth of the market. North America led the global market owing to advanced healthcare infrastructure and widespread access to prescription and OTC medications.

Content

  • Last Updated: 30 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The antipyretic and analgesic drugs market is worth USD 49.89 billion in 2025, and by 2034, it is forecasted to hit USD 77.99 billion, registering a CAGR of 5.09% over the decade.

North America is leading the antipyretic and analgesic drugs market share by 37% due to the robust R&D activities, presence of major key players, and favorable reimbursement policies.

The antipyretic and analgesic drugs market includes six segments, including by drug type, by mechanism of action, by route of administration, by indication, by end user, and by region.

Antipyretic drugs reduce fever, while analgesic drugs relieve pain. Common examples include acetaminophen, ibuprofen, and aspirin. They are widely used for headaches, musculoskeletal pain, fever, and post-operative discomfort.

Oral administration dominates due to convenience and patient compliance. Injectable formulations are growing rapidly for acute pain management and hospital use.

International Association for the Study of Pain (IASP), Food and Drug Administration, Indian Society of Pain Clinicians (ISPC), clinicaltrials.gov, American Society of Regional Anesthesia and Pain Medicine (ASRA), WHO, Asian Pain Academy, JAMA, European Pain Federation (EFIC), GOV.UK
Any Questions